Canadians' preferences for receiving incidental findings from genetic testing
2015-03-09
(Press-News.org) Although many people value receiving information about incidental findings identified from genomic sequencing, not everyone wants to know about genetic conditions regardless of potential health implications, found a study of Canadian preferences in CMAJ (Canadian Medical Association Journal).
An incidental finding refers to discovery of a genetic condition that may cause a disease, but the finding is unrelated to why genomic testing was initially ordered by the physician. For example, a test to determine if there is a genetic cause of a patient's colon cancer may find that the patient is at risk of other diseases unrelated to the diagnosis. For some diseases identified incidentally, treatment may not be available.
Advances in technology and research indicate that individual genomic sequencing will soon be available to help provide individual-specific health care, although there is debate over whether people should be informed about incidental findings.
A survey of 1200 people set out to understand Canadians' preferences for hearing about incidental findings discovered during genetic testing that indicate possible risks for other diseases.
"We found that most participants valued receiving news of incidental findings, but that personal utility depended on the type of findings uncovered, and that not all participants wanted to receive results, regardless of potential health implications," states Dr. Dean Regier, Canadian Centre for Applied Research in Cancer Control, BC Cancer Agency, and School of Population and Public Health, University of British Columbia.
People thought it useful to hear about diseases for which they were at risk (80%-90%) if there were lifestyle modifications or medical treatment available. If risk of diseases that had no treatment or those that had mild health effects were detected incidentally, the information was less useful to people and could negatively affect quality of life. However, preferences for receiving this information varied.
"We also found evidence of benefit related to offering participants a choice between receipt of incidental findings for both treatable and untreatable diseases or receipt of information about incidental findings for diseases with only medical intervention available."
The authors suggest that individuals should be offered an informed choice about the types of incidental findings from clinical genomic sequencing they prefer to be told about.
INFORMATION:
ELSE PRESS RELEASES FROM THIS DATE:
2015-03-09
In a screen of more than 100,000 potential drugs, only one, harmine, drove human insulin-producing beta cells to multiply, according to a study led by researchers at the Icahn School of Medicine at Mount Sinai, funded by JDRF and the National Institutes of Health, and published online today in Nature Medicine.
Diabetes results from too few insulin-producing "beta cells" in the pancreas secreting too little insulin, the hormone required to keep blood sugar levels in the normal range. The disease affects 380 million people worldwide, and leads to major medical complications: ...
2015-03-09
COLLEGE PARK, Md. -- An analysis of changes to the climate that occur over several decades suggests that these changes are happening faster than historical levels and are starting to speed up. The Earth is now entering a period of changing climate that will likely be faster than what's occurred naturally over the last thousand years, according to a new paper in Nature Climate Change, committing people to live through and adapt to a warming world.
In this study, interdisciplinary scientist Steve Smith and colleagues at the Department of Energy's Pacific Northwest National ...
2015-03-09
Activity in a brain area known as the dorsal posterior insula is directly related to the intensity of pain, a brain imaging study of 17 people has found.
Researchers at the Oxford Centre for Functional Magnetic Resonance Imaging of the Brain used a new brain imaging technique to look at people experiencing pain over many hours. Activity in only one brain area, the dorsal posterior insula, reflected the participants' ratings of how much the pain hurt.
These results, published in the journal Nature Neuroscience, could help detect pain in people with limited communication ...
2015-03-09
Scientists have discovered another 15 genetic 'hot-spots' that can increase a woman's risk of developing breast cancer, according to research published today (Monday) in Nature Genetics.
In a study funded by Cancer Research UK*, scientists compared tiny variations in the genetic make-up of more than 120,000 women of European ancestry, with and without breast cancer, and identified 15 new variations - called single nucleotide polymorphisms (SNPs) - that are linked to a higher risk of the disease.
This new discovery means that a total of more than 90 SNPs associated with ...
2015-03-09
Kansas City, MO. -- All the cells in an organism carry the same instruction manual, the DNA, but different cells read and express different portions of it in order fulfill specific functions in the body. For example, nerve cells express genes that help them send messages to other nerve cells, whereas immune cells express genes that help them make antibodies.
In large part, this highly regulated process of gene expression is what makes us fully functioning, complex beings, rather than a blob of like-minded cells.
Despite its importance, researchers still do not completely ...
2015-03-09
PHILADELPHIA--Treating metastatic melanoma with a triple threat--including radiation therapy and two immunotherapies that target the CTLA4 and PD-1 pathways--could elicit an optimal response in more patients, one that will boost the immune system's attack on the disease, suggests a new study from a multidisciplinary team of researchers from Penn's Abramson Cancer Center published today in Nature.
The study, led by senior authors Andy J. Minn, MD, PhD, assistant professor of Radiation Oncology, Robert Vonderheide, MD, DPhil, the Hanna Wise Professor in Cancer Research, ...
2015-03-09
A collaborative effort between investigators at the Yerkes National Primate Research Center, Emory University School of Medicine and Georgia Institute of Technology has led to the development of a non-invasive method to image simian immunodeficiency virus (SIV) replication in real-time, in vivo.
This approach, which is reported today in Nature Methods' Advance Online Publication, is based on immune positron-emission tomography/computed tomography (PET/CT) and allows for the capture of viral dynamics of SIV, the animal model of human HIV infection. This novel approach ...
2015-03-09
A new study of acute lymphoblastic leukemia (ALL), a blood cancer that primarily affects young children, has revealed that the disease has two distinct subtypes, and provides preliminary evidence that about 13 percent of ALL cases may be successfully treated with targeted drugs that have proved highly effective in the treatment of lymphomas in adults.
Usually emerging in children between 2 and 5 years of age, ALL occurs when the proliferation of white blood cells known as lymphocytes spirals out of control. The current standard of care for ALL employs high doses of chemotherapy ...
2015-03-09
A process that is too fast to be measured and analysed. Yet a group of international scientists did not lose heart and conceived a sort of highly sophisticated moviola film-editing system, which allowed them to observe - for the first time in a direct manner - an effect underlying high-temperature conductivity. The results of their work have been published in Nature Physics on Monday 9 March 2015.
Superconductors have properties that make them potentially very interesting for technology (examples of application include magnetic levitation trains). The road to a true application ...
2015-03-09
Narcoleptics suffer from bouts of sleepiness and sleep attacks, which impair their ability to function in daily life. But the precise cause of narcolepsy has long eluded scientists, and the cure for the devastating neurological disorder afflicting an estimated three million people worldwide -- and one in 3,000 Americans -- remains at bay.
A new study published in Pharmacological Research by the world's leading autoimmune disease expert, Tel Aviv University's Prof. Yehuda Shoenfeld, finds that narcolepsy bears the trademarks of a classic autoimmune disorder and should ...
LAST 30 PRESS RELEASES:
[Press-News.org] Canadians' preferences for receiving incidental findings from genetic testing
